Provided by Tiger Trade Technology Pte. Ltd.

Sarepta Therapeutics

20.52
-1.5000-6.81%
Post-market: 20.51-0.0070-0.03%16:32 EDT
Volume:2.20M
Turnover:45.53M
Market Cap:2.17B
PE:-15.59
High:22.02
Open:22.02
Low:20.28
Close:22.02
52wk High:25.32
52wk Low:14.68
Shares:105.57M
Float Shares:99.05M
Volume Ratio:0.53
T/O Rate:2.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3161
EPS(LYR):-7.1300
ROE:-9.48%
ROA:-1.13%
PB:1.42
PE(LYR):-2.88

Loading ...

Roche decision could hurt Sarepta in U.S., says H.C. Wainwright

TIPRANKS
·
Apr 17

A Look At Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Swings

Simply Wall St.
·
Apr 10

RBC Adjusts Price Target on Sarepta Therapeutics to $19 From $18, Maintains Sector Perform Rating

MT Newswires Live
·
Apr 07

Is Sarepta Therapeutics (SRPT) Starting To Look Interesting Again After Recent Share Price Rebound

Simply Wall St.
·
Apr 07

Wells Fargo Remains a Buy on Sarepta Therapeutics (SRPT)

TIPRANKS
·
Apr 01

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 01

Sarepta Therapeutics Is Maintained at Sell by Citigroup

Dow Jones
·
Mar 26

Deutsche ups Sarepta target, says 35% stock rally overdone

TIPRANKS
·
Mar 26

Sarepta price target raised to $35 from $29 at Wedbush

TIPRANKS
·
Mar 26

Wedbush Raises Price Target on Sarepta Therapeutics to $35 From $29, Keeps Outperform Rating

MT Newswires Live
·
Mar 26

Sarepta Therapeutics, Inc. : Deutsche Bank Raises Target Price to $14 From $12

THOMSON REUTERS
·
Mar 26

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Vertex Pharmaceuticals (VRTX) and Sarepta Therapeutics (SRPT)

TIPRANKS
·
Mar 26

Sarepta Therapeutics Inc : Wedbush Raises Target Price to $35 From $29

THOMSON REUTERS
·
Mar 26

Bernstein Reaffirms Their Hold Rating on Sarepta Therapeutics (SRPT)

TIPRANKS
·
Mar 26

Sarepta Therapeutics: Early TRiM Platform Promise Outweighed by High Clinical Risk and Valuation Downside, Justifying Sell Rating

TIPRANKS
·
Mar 26

Sarepta price target raised to $13 from $9 at Citi

TIPRANKS
·
Mar 26

U.S. RESEARCH ROUNDUP- Equitable Holdings, Robinhood Markets, Wingstop

Reuters
·
Mar 26

Barclays Sticks to Its Hold Rating for Sarepta Therapeutics (SRPT)

TIPRANKS
·
Mar 26

Sarepta Therapeutics Inc : Piper Sandler Raises Target Price to $23 From $16

THOMSON REUTERS
·
Mar 26

ETF Daily | SRPU Soars 69%; FLYT Surges 37%; ARMG Jumps 33%; Space and Semiconductor Themes Lead

ETF Tracker
·
Mar 26